Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment
Cell · 2024-12 · 187 (26) · 7470-7491.e32
DOI: 10.1016/j.cell.2024.10.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2024-12. Verfasst von Feng Lin und 22 weiteren Autor:innen. Beteiligte Einrichtung: Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecula…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Immunotherapy. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 141 Literaturangaben. Gefördert von: Tencent, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Although immunotherapy has revolutionized cancer treatment, its efficacy is affected by multiple factors, particularly those derived from the complexity and heterogeneity of the tumor-immune microenvironment (TIME). Strategies that simultaneously and synergistically engage multiple immune cells in TIME remain highly desirable but challenging. Herein, we report a multimodal and programmable platform that enables the integration of multiple therapeutic modules into single agents for tumor-targeted co-engagement of multiple immune cells within TIME. We developed the triple orthogonal linker (T-Linker) technology to integrate various therapeutic small molecules and biomolecules as multimodal targeting chimeras (Multi-TACs). The EGFR-CD3-PDL1 Multi-TAC facilitated T-dendritic cell co-engagement to target solid tumors with excellent efficacy, as demonstrated in vitro, in several humanized mouse models and in patient-derived tumor models. Furthermore, Multi-TACs were constructed to coordinate T cells with other immune cell types. The highly modular and programmable feature of our Multi-TACs may find broad applications in immunotherapy and beyond.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molec…
- Department of Biomedical Engineering, College of Future Technology, Peking University, Beijing 100871, China.
- National Resource Center for Mutant Mice, MOE Key Laboratory of Model Animals for Disease Study, Jiangsu Key Laboratory of Molecular Medicine, Model Animal Research Center, Medical School of Nanjing University, Nanjing…
- Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), First Department of Thoracic Surgery, Peking University Cancer Hospital and Institute, Beijing 100142, China.
- State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
Förderung
- Tencent
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Lin, F., Yin, S., Zhang, Z., Yu, Y., Fang, H., Liang, Z., Zhu, R., Zhou, H., Li, J., Cao, K., Guo, W., Qin, S., Zhang, Y., Lu, C., Li, H., Liu, S., Zhang, H., Ye, B., Lin, J., …, & Chen, P. R. (2024). Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment. Cell, 187(26), 7470-7491.e32. https://doi.org/10.1016/j.cell.2024.10.016
Vancouver
Lin F, Yin S, Zhang Z, Yu Y, Fang H, Liang Z, et al. Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment. Cell. 2024;187(26):7470-7491.e32. doi:10.1016/j.cell.2024.10.016
BibTeX
@article{Lin2024,
author = {Lin, Feng and Yin, Shenyi and Zhang, Zijian and Yu, Ying and Fang, Haoming and Liang, Zhen and Zhu, Rujie and Zhou, Haitao and Li, Jianjie and Cao, Kunxia and Guo, Weiming and Qin, Shan and Zhang, Yuxuan and Lu, Chenghao and Li, Han and Liu, Shibo and Zhang, Heng and Ye, Buqing and Lin, Jian and Li, Yan and Kang, Xiaozheng and Xi, Jianzhong Jeff and Chen, Peng R},
title = {Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment},
journal = {Cell},
year = {2024},
volume = {187},
number = {26},
pages = {7470--7491.e32},
doi = {10.1016/j.cell.2024.10.016}
}
EUVIMED